Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nuria Murtra-Garrell"'
Autor:
Pablo Martinez, Javier Hernández-Losa, Ma Ángeles Montero, Susana Cedrés, Josep Castellví, Alex Martinez-Marti, Natalia Tallada, Nuria Murtra-Garrell, Alejandro Navarro-Mendivill, Victor Rodriguez-Freixinos, Mercedes Canela, Santiago Ramon y Cajal, Enriqueta Felip
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e52261 (2013)
BackgroundAnaplastic Lymphoma Kinase (ALK) positivity represents a novel molecular target in a subset of Non-Small Cell Lung Cancers (NSCLC). We explore Fluorescence in situ Hybridization (FISH) and Immunohistochemistry (IHC) as diagnostic methods fo
Externí odkaz:
https://doaj.org/article/75cb04320c0e4cf28861147ab50dc764
Autor:
Susana Cedres, Alex Martinez-Marti, Alejandro Navarro-Mendivill, Pablo Martinez, Enriqueta Felip, Javier Hernández-Losa, Mercedes Canela, Nuria Murtra-Garrell, Natalia Tallada, M. A. Montero, Victor Rodriguez-Freixinos, Josep Castellví, Santiago Ramón y Cajal
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 1, p e52261 (2013)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
PLoS ONE, Vol 8, Iss 1, p e52261 (2013)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
BackgroundAnaplastic Lymphoma Kinase (ALK) positivity represents a novel molecular target in a subset of Non-Small Cell Lung Cancers (NSCLC). We explore Fluorescence in situ Hybridization (FISH) and Immunohistochemistry (IHC) as diagnostic methods fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d5fe267c4f04e4d8aff564d8187b947
http://europepmc.org/articles/PMC3554741
http://europepmc.org/articles/PMC3554741
Autor:
Pablo Martinez, Paolo Nuciforo, Alejandro Navarro, Laura Layos Romero, Enriqueta Felip, Irene Sansano, Susana Cedres, Francesc Salvà, Nuria Murtra-Garrell, Alex Martinez Marti
Publikováno v:
Journal of Clinical Oncology. 32:7569-7569
7569 Background: Recent clinical trials have shown that immune-checkpoint blockade can result in striking and durable responses in advanced non-small cell lung cancer. Preliminary data suggest a re...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7554e044ee5490727a9fdce2aaa075f8
https://doi.org/10.1200/jco.2014.32.15_suppl.7569
https://doi.org/10.1200/jco.2014.32.15_suppl.7569
Autor:
Pablo Martinez, I. Sullivan, Nuria Murtra-Garrell, Ludmila Prudkin, Javier Hernández-Losa, Susana Cedres, Esther Zamora, Santiago Ramón y Cajal, Enriqueta Felip, Alex Martinez Marti, Alejandro Navarro, Maite Salcedo, Claudia Aura, Mercedes Canela, José Antonio Jiménez, Josep Tabernero, Maria Angeles Montero
Publikováno v:
Journal of Clinical Oncology. 30:7041-7041
7041 Background: The FGFR1 gene is located in the chromosomal region 8p12 and encodes a transmembrane receptor tyrosine kinase. Amplification of FGFR1 has been reported in lung cancer, predominantly in SCC (in up to ~ 20%) and has been considered a p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05ebf4159bad180520d4fcaa43ed60e1
https://doi.org/10.1200/jco.2012.30.15_suppl.7041
https://doi.org/10.1200/jco.2012.30.15_suppl.7041
Autor:
M. A. Montero, J. Tabernero, Enriqueta Felip, Cristina Teixidó, Mercedes Canela, Pilar Rodríguez Martínez, V. Freixinos, Esther Pallisa, I. Nunez, S. Ramón y Cajal, E. Lopez, Nuria Murtra-Garrell, Mayte Salcedo, Vicente Peg, Atilio Navarro, Javier Hernández-Losa, Guillem Argiles, Natalia Tallada, Susana Cedres
Publikováno v:
Journal of Clinical Oncology. 29:7037-7037
7037 Background: EGFR deregulation has been extensively studied in NSCLC, but less is known about the expression and role of other ErbB receptors. The aim of this study is to determine ErbB2 and Er...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28907e1f4a77d3d8d5d3a179e859c766
https://doi.org/10.1200/jco.2011.29.15_suppl.7037
https://doi.org/10.1200/jco.2011.29.15_suppl.7037
Autor:
Nuria Murtra-Garrell, Daniel Silberschmidt, Ana Vivancos, Ginevra Caratu, Mercedes Canela, Alex Martinez Marti, José Antonio Jiménez, Paolo Nuciforo, Ludmila Prudkin, Pablo Martinez, Susana Cedres, Enriqueta Felip, Alejandro Navarro-Mendivil, Hector G. Palmer, Pilar de la Morena
Publikováno v:
Publons
8070 Background: The majority of lung ADC tumors are characterized by specific genetic features with KRAS mutations (mut) seen in 20-30%, EGFR mut in 15%, EML4-ALK translocations in 5%, and ERBB2 mut in 2%, among others. Some of these genetic alterat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18f3a3ef9f3017493af1798a2e124b54
https://publons.com/publon/20202952/
https://publons.com/publon/20202952/
